This inventor holds 7 USPTO granted patents and 7 published patent applications and 5 EPO patents. Top assignees: Eisai Company, Limited, Tokyo Medical University, Nec Corporation. Active years: 2001-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JP (2001 - 2007)
- Kanagawa, JP (2014)
- Isehara, JP (2014 - 2015)
Company Filing History:
3 out of 677 
3 out of 11 
2 out of 36,718 
Years Active: 2001-2025
Title: Masakatsu Takanashi: Innovator in Cancer Research
Introduction
Masakatsu Takanashi is a prominent inventor based in Isehara, Japan. He has made significant contributions to the field of cancer research, holding a total of 7 patents. His work focuses on developing innovative cancer markers and evaluation methods that enhance the understanding and treatment of various cancers.
Latest Patents
Takanashi's latest patents include groundbreaking inventions such as a cancer marker and a method for evaluating cancer using this marker. The invention provides a novel cancer marker for assessing the onset, preclinical stage, clinical stage, or prognosis of cancer in a subject. This cancer marker utilizes at least one miRNA selected from hsa-miR-92 and hsa-miR-494, specifically for cancers excluding breast cancer. The evaluation method involves detecting the expression level of this cancer marker in biological samples collected from subjects. Additionally, he has developed a cancer cell identification marker and a cancer cell proliferation inhibitor. This identification marker is crucial for detecting various human cancer cells and is closely related to malignant alterations in cells. The treatment compositions based on this marker aim to suppress cancer cell proliferation by inhibiting the expression of the human heterochromatin protein 1γ (HP1γ) gene.
Career Highlights
Throughout his career, Takanashi has worked with notable companies such as Eisai Company, Limited and NEC Corporation. His experience in these organizations has contributed to his expertise in cancer research and innovation.
Collaborations
Takanashi has collaborated with esteemed colleagues, including Masahiko Kuroda and Kosuke Oikawa. These partnerships have further enriched his research and development efforts in the field of cancer treatment.
Conclusion
Masakatsu Takanashi's innovative work in cancer research has led to significant advancements in the evaluation and treatment of cancer. His contributions continue to impact the medical field positively, showcasing the importance of innovation in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile